Vital Hepatitis Reactivation with Anti-Tumor Necrosis Factor-Alpha: What Do We Know?

被引：0
作者：
Zuckerman, Eli [1 ]
机构：
[1] Technion Israel Inst Technol, Rappaport Fac Med, Carmel Med Ctr, Liver Unit, Haifa, Israel
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2013年 / 15卷 / 06期
关键词：
reactivation; hepatitis B virus (HBV); hepatitis C virus (HCV); anti-tumor necrosis factor-alpha (anti-TNF alpha); preemptive treatment; immunosuppression; B-VIRUS INFECTION; CYTOTOXIC CHEMOTHERAPY; C INFECTION; DISEASE; PREVENTION; LAMIVUDINE; THERAPY; SAFETY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：298 / 300
页数：3
相关论文
共 50 条
  • [31] Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha
    Matar, Manar
    Levi, Rachel
    Zvuloni, Maya
    Shamir, Raanan
    Assa, Amit
    PEDIATRIC RESEARCH, 2023, 93 (01) : 131 - 136
  • [32] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Kempinski, Radoslaw
    Poniewierka, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02): : 143 - 149
  • [33] Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease
    Kim, Hyun Woo
    Lee, Chang-Keun
    Cha, Hoon-Suk
    Choe, Jung-Yoon
    Park, Eun-Jung
    Kim, Jinseok
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (04) : 727 - 734
  • [34] Induction of vascular leak syndrome by tumor necrosis factor-alpha alone
    Park, Kyung-Yeon
    Kim, Sung-Jo
    Oh, Euichaul
    Heo, Tae-Hwe
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 213 - 216
  • [35] A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease
    Papamichael, Konstantinos
    Mantzaris, Gerassimos J.
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 493 - 501
  • [36] Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma
    Wang, Hongmei
    Liu, Jianmin
    Hu, Xuemei
    Liu, Shanshan
    He, Baojun
    MEDICAL SCIENCE MONITOR, 2016, 22 : 3694 - 3704
  • [37] Bench to bedside: Tumor necrosis factor-alpha: From inflammation to resuscitation
    Cairns, CB
    Panacek, EA
    Harken, AH
    Banerjee, A
    ACADEMIC EMERGENCY MEDICINE, 2000, 7 (08) : 930 - 941
  • [38] Tumor necrosis factor-alpha gene polymorphism in Turkish patients with psoriasis
    Yeniay, Yildiray
    Koc, Erol
    Akar, Hatice
    META GENE, 2021, 28
  • [39] Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response
    Cacciapaglia, Fabio
    Anelli, Maria Grazia
    Rinaldi, Angela
    Serafino, Lucia
    Covelli, Michele
    Scioscia, Crescenzio
    Iannone, Florenzo
    Lapadula, Giovanni
    DRUG DEVELOPMENT RESEARCH, 2014, 75 : S77 - S80
  • [40] Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C
    Salvi, Monica
    Macaluso, Laura
    Luci, Cecilia
    Mattozzi, Carlo
    Paolino, Giovanni
    Aprea, Yvonne
    Calvieri, Stefano
    Richetta, Antonio Giovanni
    WORLD JOURNAL OF CLINICAL CASES, 2016, 4 (02) : 49 - 55
12345